Navigation Links
3-Drug Combo Improves Advanced Pancreatic Cancer Outcomes
Date:6/2/2008

Study finds treatment well-tolerated, kept tumors stable for almost 6 months

MONDAY, June 2 (HealthDay News) -- A combination therapy of gemcitabine, capecitabine and bevacizumab improves outcomes in patients with advanced pancreatic cancer, according to a multi-center study led by researchers at Roswell Park Cancer Institute in Buffalo, N.Y.

The study of 50 patients found that this combination treatment was well-tolerated by patients, was able to prevent tumors from progressing for almost six months, and improved median survival to 9.8 months.

The study was expected to be presented Monday at the American Society of Clinical Oncology annual meeting, in Chicago.

Patients with advanced pancreatic cancer -- one of the most deadly types of solid tumors -- have a median survival of six months after diagnosis. About 37,680 people in the United States will be diagnosed with pancreatic cancer in 2008.

While gemcitabine and capecitabine have improved quality of life for patients with advanced pancreatic cancer, they haven't led to a significant improvement in survival time, according to background information in the study.

Bevacizumab, which reduces blood supply to tumor, has improved outcomes when added to chemotherapy for patients with colon, lung and breast cancers.

More information

The National Cancer Institute has more about pancreatic cancer.



-- Robert Preidt



SOURCE: Roswell Park Cancer Institute, news release, June 2, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. 3-drug combination extremely promising as first-line therapy for multiple myeloma
2. Radiation and drug combo helps boost efficacy of lung cancer treatment
3. Aerobic, Weight Training Combo Best Against Diabetes
4. New antibiotic drug combo to speed up treatment of tuberculosis
5. Drug Combo Helps Fight Marfan Syndrome
6. Drug Combo Blocks Pain Without Impairing Movement
7. Two-Drug Combo Fights Brain Tumors
8. CPR, Defibrillator Combo Boosts Cardiac Incident Survival
9. Drug Combo Boosts Multiple Myeloma Survival
10. Drug Combos Effective Against Rheumatoid Arthritis
11. Combo PET/CT Scan Helps Spot Breast Cancers Spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 2016 , ... For many years, Andrew G. Zubinas has accumulated ... beauty of the Lithuanian language and its poetry inspired him in writing ... lyrically explores all aspects of a living, breathing forest where nothing ever stays the ...
(Date:12/5/2016)... ... December 05, 2016 , ... T.E.N., ... that nominations will be accepted from December 5, 2016 through March 3, ... include the Information Security Executive® of the Year, which recognizes executives who ...
(Date:12/5/2016)... ... December 05, 2016 , ... Worldwise ®, a ... design firm kathy ireland® Worldwide for five additional years, announced by Kevin Fick, ... exclusive licensing agreement three years ago to design and develop the kathy ireland® ...
(Date:12/5/2016)... York, NY (PRWEB) , ... December 05, 2016 ... ... companies to use a patent-pending blend of L-Citrulline and glutathione to enhance production ... Blend, a combination that studies have shown to produce NO twice as effectively ...
(Date:12/5/2016)... Nashville, Tennessee (PRWEB) , ... ... ... leader in strategic interoperability, today announced that the company will provide alerting ... platform. CIHIE has been recently awarded $1.7 million in federal funds as ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)...  Recently Zymo Research announced an exclusive license ... Horvath,s Clock. Based on this technology, Zymo Research ... academic and biopharma scientific researchers to determine the ... sperm. The service quantifies changes in ... chronological age following drug treatments and identifies disease ...
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson and ... medical technology company, will demonstrate an enhanced technology platform ... technologies, including the company,s leading Pyxis™ and Alaris™ systems, ... (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 percent ...
(Date:12/5/2016)... 5, 2016 Research and Markets has announced ... Test Market Size, Share, Development, Growth and Demand Forecast to 2022" ... ... female fertility and pregnancy rapid test market is expected to grow ... and pregnancy rapid test market is witnessing high growth, due to ...
Breaking Medicine Technology: